CD8A and melanoma: Supporting this, an in vitro study using both mouse and human tumor cell lines from melanoma, colon cancer, breast cancer, and hepatocellular carcinoma revealed that tumor-repopulating cells evade cytolytic CD8+ T-cell killing by exploiting their mechanical softness (123).